Glomérulopathies associées aux syndromes myéloprolifératifs

[1]  V. D’Agati,et al.  Myeloproliferative neoplasms cause glomerulopathy. , 2011, Kidney international.

[2]  M. Haas,et al.  Glomerular diseases associated with hematopoietic neoplasms: an expanding spectrum. , 2011, Kidney international.

[3]  I. Elalamy,et al.  Thrombose de l’aorte et infarctus spléniques révélateurs d’une thrombocytémie essentielle , 2011 .

[4]  L. Daniel,et al.  Les atteintes rénales au cours des hémopathies malignes. Stratégie diagnostique , 2010 .

[5]  P. Richardson,et al.  Kidney disease associated with plasma cell dyscrasias. , 2010, Blood.

[6]  F. Cakalagaoglu,et al.  Focal Segmental Glomerulosclerosis Associated with Idiopathic Myelofibrosis , 2010, Renal failure.

[7]  O. Lambotte,et al.  Glomerular Lesions in Patients With Sickle Cell Disease , 2010, Medicine.

[8]  M. Mizuno,et al.  Acute kidney injury presenting a feature of leukemic infiltration during therapy for chronic myelogenous leukemia. , 2010, Internal medicine.

[9]  A. Tfayli,et al.  Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia , 2009, Journal of clinical pharmacy and therapeutics.

[10]  C. Bloomfield,et al.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. , 2009, Blood.

[11]  C. Alpers,et al.  A new look at platelet-derived growth factor in renal disease. , 2008, Journal of the American Society of Nephrology : JASN.

[12]  A. Komatsuda,et al.  Focal segmental glomerulosclerosis associated with polycythemia vera: report of a case and review of the literature. , 2007, Clinical nephrology.

[13]  Y. Kikuchi,et al.  A case of essential thrombocytosis developing nephrotic syndrome and severe endothelial damage. , 2006, Journal of nephrology.

[14]  N. Brousse,et al.  Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature. , 2006, Kidney international.

[15]  J. Reilly.  Idiopathic myelofibrosis: pathogenesis to treatment , 2006, Hematological oncology.

[16]  Nong Zhang,et al.  Aldose reductase regulates TGF‐β1‐induced production of fibronectin and type IV collagen in cultured rat mesangial cells , 2006, Nephrology.

[17]  T. Kondo,et al.  Focal segmental glomerulosclerosis associated with essential thrombocythemia , 2006, Clinical and Experimental Nephrology.

[18]  S. Shankland,et al.  The cyclin-dependent kinase inhibitor p21 is required for TGF-β1-induced podocyte apoptosis , 2005 .

[19]  B. Barlogie,et al.  Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. , 2009, Archives of pathology & laboratory medicine.

[20]  A. Dispenzieri,et al.  Excessive Weight Gain during Mobilization Increases First Year Mortality Following High Dose Therapy and Stem Cell Transplantation in Patients with Primary Amyloidosis. , 2004 .

[21]  J. Goujon,et al.  Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features. , 2002, Kidney international.

[22]  G. Pamuk,et al.  Nephrotic Syndrome Associated with Agnogenic Myeloid Metaplasia , 2002, Leukemia & lymphoma.

[23]  E. Bottinger,et al.  Apoptosis in podocytes induced by TGF-β and Smad7 , 2001 .

[24]  F. Matzkies,et al.  Focal sclerosis with tip lesions secondary to polycythaemia vera. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  D. C. Han,et al.  Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. , 2000, American journal of physiology. Renal physiology.

[26]  K. Chan,et al.  Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[27]  K. Lehmann,et al.  Idiopathic myelofibrosis with extramedullary hematopoiesis in the kidneys. , 1999, Clinical nephrology.

[28]  P. Wollan,et al.  Population‐based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted county study, 1976–1995 , 1999, American journal of hematology.

[29]  M. Martyré.  TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. , 1995, Leukemia & lymphoma.

[30]  H. Kohli,et al.  Focal segmental glomerulosclerosis in a patient with polycythemia rubra vera. , 1995, Nephron.

[31]  L. Melton,et al.  Trends in the incidence of polycythemia vera among olmsted county, Minnesota residents, 1935–1989 , 1994, American journal of hematology.

[32]  M. Perazella,et al.  Nephrotic syndrome associated with agnogenic myeloid metaplasia. , 1994, American journal of nephrology.

[33]  J. Fillastre,et al.  Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. , 1992, Kidney international.

[34]  G. Striker,et al.  Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[35]  C. Alpers,et al.  Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. , 1992, Kidney international.

[36]  A. Gown,et al.  Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Bryckaert,et al.  Increased intraplatelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasia , 1991, British journal of haematology.

[38]  E. Ruoslahti,et al.  Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. , 1990, The Journal of clinical investigation.

[39]  J. Guarderas,et al.  Acute renal failure in a patient with essential thrombocythemia, diabetes mellitus, and heterozygous hemoglobin C disease. , 1990, Southern medical journal.

[40]  V. Millet,et al.  Essential thrombocytosis with acute renal failure due to bilateral thrombosis of the renal arteries and veins. , 1982 .